These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26264744)

  • 1. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure.
    Khovanova N; Daga S; Shaikhina T; Krishnan N; Jones J; Zehnder D; Mitchell D; Higgins R; Briggs D; Lowe D
    Transpl Int; 2015 Dec; 28(12):1405-15. PubMed ID: 26264744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
    Arnold ML; Ntokou IS; Doxiadis II; Spriewald BM; Boletis JN; Iniotaki AG
    Transpl Int; 2014 Mar; 27(3):253-61. PubMed ID: 24118579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry.
    Lee H; Lee H; Sun IO; Park JH; Park JW; Ban TH; Yang J; Kim MS; Yang CW; Chung BH;
    Front Immunol; 2024; 15():1420351. PubMed ID: 39055708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.
    Babu A; Andreou A; Briggs D; Krishnan N; Higgins R; Mitchell D; Barber T; Daga S
    Clin Transpl; 2016; 32():173-179. PubMed ID: 28564535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-Specific Antibodies in Kidney Transplant Recipients.
    Zhang R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):182-192. PubMed ID: 28446536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of
    Pernin V; Beyze A; Szwarc I; Bec N; Salsac C; Perez-Garcia E; Mourad G; Merville P; Visentin J; Perrochia H; Larroque C; Couzi L; Le Quintrec M
    Front Immunol; 2020; 11():919. PubMed ID: 32670261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
    Cicciarelli JC; Kasahara N; Lemp NA; Adamson R; Dembitsky W; Browne B; Steinberg S
    Clin Transpl; 2013; ():413-22. PubMed ID: 25095537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.
    Jackson AM; Kanaparthi S; Burrell BE; Lucas DP; Vega RM; Demetris AJ; Feng S
    Am J Transplant; 2020 Feb; 20(2):513-524. PubMed ID: 31561279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients.
    Hamdani G; Goebel JW; Brailey P; Portwood EA; Hooper DK; Girnita AL
    Pediatr Transplant; 2018 Aug; 22(5):e13219. PubMed ID: 29855114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R; Lowe D; Hathaway M; Williams C; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Daga S; Edey M; Zehnder D; Briggs D
    Transplantation; 2011 Oct; 92(8):900-6. PubMed ID: 21968524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection.
    Hönger G; Hopfer H; Arnold ML; Spriewald BM; Schaub S; Amico P
    Transplantation; 2011 Jul; 92(1):41-7. PubMed ID: 21637140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
    Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
    Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Hum Immunol; 2017 Sep; 78(9):526-533. PubMed ID: 28732720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.